Idiopathic pulmonary fibrosis: is all-cause mortality a practical and realistic end-point for clinical trials?

Thorax. 2013 May;68(5):491-2. doi: 10.1136/thoraxjnl-2012-203114. Epub 2013 Jan 23.

Authors

Tamera Jo Corte, Nicole S Goh, Ian N Glaspole, Christopher J Zappala, Peter M Hopkins, Margaret L Wilsher

PMID: 23345573
DOI: 10.1136/thoraxjnl-2012-203114

No abstract available

Publication types

Letter
Comment

MeSH terms

Clinical Trials as Topic / methods*
Humans
Idiopathic Pulmonary Fibrosis / mortality*
Idiopathic Pulmonary Fibrosis / therapy*